US L-Histidine Market Summary
The US L-Histidine Market is projected to grow significantly from 165.9 million USD in 2024 to 447 million USD by 2035.
Key Market Trends & Highlights
US L-Histidine Market Key Trends and Highlights
- The US L-Histidine Market is valued at 165.9 million USD in 2024.
- By 2035, the market is expected to reach 447 million USD, indicating robust growth.
- The compound annual growth rate (CAGR) for the period from 2025 to 2035 is estimated at 9.43 percent.
- Growing adoption of L-Histidine in the pharmaceutical sector due to its therapeutic benefits is a major market driver.
Market Size & Forecast
| 2024 Market Size | 165.9 (USD Million) |
| 2035 Market Size | 447 (USD Million) |
| CAGR (2025-2035) | 9.43% |
Major Players
Ajinomoto, BASF, Toray Industries, Nexira, Kyowa Hakko Bio, Hefei TNJ Chemical Industry, Fufeng Group, NutraScience Labs, Hunan Reshine Pharmaceutical, Amway, Merck Group, Shaanxi Kintor Pharmaceutical, Cargill, Everett Smith Group, Nanjing Zelang Medical Technology